IL6 and metabolic dysfunction-associated steatotic liver disease: The role of interleukin-6 (IL-6) concerning the severity of hepatocyte inflammation, staging of fibrosis and insulin resistance in NASH and NAFLD, has been reviewed in the literature by various authors 2324.